Folic acid is the synthetic form of folate, also known as vitamin B9, and it is one of the eight B-complex vitamins essential for human health. The natural form found in food is called folate (or dietary folate), while folic acid is the stable manufactured form used in supplements and food fortification because it survives storage and cooking better than natural folate. Once absorbed, folic acid is converted in the body to its active form, 5-methyltetrahydrofolate (5-MTHF), which is the form actually used by cells. Both folate and folic acid are biologically useful and effective for preventing neural tube defects when intake is adequate.

Folate's core jobs in the body are DNA synthesis, cell division and the methylation reactions that switch genes on and off. Because the embryo in early pregnancy is dividing cells at an extraordinary rate, folate demand spikes dramatically in the first weeks after conception. The neural tube — the embryo's earliest brain and spinal cord structure — depends critically on adequate folate at the moment it closes, and a folate shortfall at that exact moment can leave the tube open. This is the biological basis for the link between folate status and NTDs, and the reason every reproductive-age woman is told to ensure adequate intake.

The neural tube of the embryo closes by day 28 after conception. In real-world terms, this means the tube closes around the time of a missed period or just before, which is usually before a woman has taken a pregnancy test or knows she is expecting. Folic acid started after a positive pregnancy test is therefore already too late to prevent most NTDs — the tube has already closed (correctly or incorrectly) by the time the supplement begins. The window for prevention is the weeks before conception and the very first weeks after, which means folic acid must be on board before the woman is pregnant.

The evidence for the benefit is strong and consistent. Adequate folic acid started at least 1 month and ideally 3 months before conception and continued through the first trimester prevents around 70 percent of neural tube defects, including spina bifida (where the spinal cord is exposed and is the most common NTD) and anencephaly (where parts of the brain and skull do not form and which is uniformly fatal). The reduction in absolute numbers is dramatic, and the cost of a 90-day folic acid course is under 200 rupees in private pharmacies and free at every PHC under government programmes.

India carries one of the highest NTD burdens in the world. Indian hospital and community studies report rates of around 4 to 6 per 1000 births, compared to about 0.5 to 1 per 1000 in Western countries with mandatory folic acid food fortification. In absolute numbers this means tens of thousands of Indian babies are born each year with preventable neural tube defects, and the personal and family cost of an affected pregnancy — whether ending in stillbirth, neonatal death, lifelong disability or termination — is profound.

Several factors drive the higher Indian rate. Pre-conception folic acid uptake is low because most Indian pregnancies are not formally planned with a pre-conception consultation, and folic acid is usually started only after the first antenatal visit which is often at 8 to 12 weeks or later. Indian diets, while rich in some folate sources, often fall short of the 600 mcg per day target especially in lower-income households. Background maternal undernutrition, anaemia and B12 deficiency (especially in vegetarian women) compound the problem. India does not have mandatory folic acid fortification of staple foods like the US Canada and Australia, although some atta brands and packaged foods are voluntarily fortified.

The standard medical advice in India and globally is to start folic acid at least 3 months before trying to conceive, and to continue daily through at least the first trimester (12 weeks) and ideally throughout pregnancy. The 3-month lead time allows blood and tissue folate levels to reach the target range before conception, so that adequate folate is available at the critical neural tube closure window during the first 4 weeks after conception. Starting only at the time of trying does provide some protection but is suboptimal; starting only after a positive pregnancy test misses most of the protective window.

For couples in a longer-term plan, ideally folic acid begins at the time of marriage if pregnancy is being considered in the near future, or as soon as contraception is stopped. Because around half of all pregnancies globally and a meaningful fraction in India are not strictly planned, the broader public-health recommendation is that every reproductive-age woman who could become pregnant should consider taking a daily 400 mcg folic acid supplement as a routine. This single change in routine has one of the highest benefit-to-cost ratios in preventive medicine.

For low-risk Indian women planning a pregnancy, the standard recommended daily folic acid dose is 400 micrograms (mcg), which is the same as 0.4 milligrams (mg). This dose is the global standard from WHO, FOGSI (Federation of Obstetric and Gynaecological Societies of India), ICMR and the Ministry of Health, and is the dose in most pre-conception multivitamins and in the free IFA tablets given under Anemia Mukt Bharat (the IFA tablet contains 500 mcg of folic acid plus 60 mg of iron). After conception, the requirement rises and the NIN-ICMR recommended daily allowance during pregnancy is 600 mcg, which most pre-conception and antenatal supplements comfortably cover.

Higher-risk women need a substantially higher dose — typically 4 to 5 mg per day, which is roughly 10 times the standard dose. The high-dose indications are a previous baby with an NTD (the risk of recurrence is much higher than baseline), pre-existing type 1 or type 2 diabetes (which independently increases NTD risk), use of certain anti-epileptic medications (valproate carbamazepine phenytoin all interfere with folate metabolism), women with a confirmed MTHFR mutation that impairs folate processing, and women with obesity (BMI above 30) or malabsorption conditions like coeliac disease or after bariatric surgery. The high dose is prescription-only and is started under OB guidance because the right protocol depends on the individual risk.

The free public-health option is the IFA (iron-folic acid) tablet under Anemia Mukt Bharat available at every PHC, sub-centre and ASHA worker, containing 60 mg of elemental iron and 500 mcg of folic acid per tablet. This is provided free and is the backbone of the Indian government's pre-conception and antenatal nutrition programme. The same tablets are distributed during JSSK and Suraksha programmes and through the ASHA and ANM network.

Private supplements are widely available. Folvite (folic acid 5 mg) is the high-dose prescription tablet at around 50 to 200 rupees per month — note this is the high-dose form, not the standard 400 mcg, and should only be used on OB advice. Pregamin and similar pre-conception multivitamins contain around 400 to 800 mcg folic acid plus iron B12 and other micronutrients at 100 to 300 rupees per month. Becosules and similar B-complex preparations contain folic acid in smaller amounts and cost 50 to 150 rupees. Calcimax-P combines calcium and folic acid at 150 to 400 rupees. Always check the label for the exact folic acid dose.

Food sources of natural folate include leafy greens (palak methi sarson amaranth), citrus fruits (orange mosambi sweet lime), pulses (rajma chana lobia dal), nuts and seeds (peanuts almonds sunflower seeds), and fortified flours and breakfast cereals where available. A genuinely good Indian diet provides 300 to 500 mcg of folate daily, which combined with a 400 mcg supplement reliably meets the pre-conception and pregnancy target.

Folate (the natural form in food) and folic acid (the synthetic supplement form) are both biologically effective for preventing NTDs when intake is adequate, and the long-running global evidence base for NTD prevention is built on synthetic folic acid as used in supplements and fortified foods. For the vast majority of Indian women, the standard 400 mcg folic acid supplement is the right choice and is supported by decades of evidence.

A genetic variant called MTHFR (methylenetetrahydrofolate reductase) reduces the body's ability to convert folic acid to its active form 5-MTHF, and is present in a meaningful fraction of the Indian population (estimates of around 10 to 25 percent carry one variant, smaller numbers carry two). Women with confirmed MTHFR mutations, recurrent miscarriage or a personal history of NTD pregnancy are sometimes advised by the OB to take methylfolate (5-MTHF) directly instead of folic acid — brand names include Folisafe, Femitre and Mecofol. Routine MTHFR testing for all women is not currently recommended and the standard folic acid supplement remains the first-line for low-risk women.

Indian vegetarian diets can be adequate in folate when they consistently include leafy greens pulses citrus and fortified grains daily, but in practice many vegetarian and even non-vegetarian Indian women fall short. Common gaps include low daily leafy green intake (palak methi sarson eaten only occasionally rather than daily), heavy reliance on refined white flour and white rice rather than fortified atta or whole grains, low pulse intake in some regions, and seasonal dips in fresh vegetable variety. A small daily portion of cooked palak methi or another green plus a serving of dal and a citrus fruit reliably moves daily folate towards the target.

Vegan women need particular attention to vitamin B12, which is not present in plant foods and which works closely with folate in red blood cell formation and neural development. Vegan diets are usually low in B12 unless fortified foods or supplements are used, and a B12 deficiency masked by adequate folate can cause its own neurological problems. Pre-conception B12 testing and supplementation is sensible for vegan women planning a pregnancy. Iron-folic-acid combined supplements under Anemia Mukt Bharat are free at every PHC and cover the folic acid plus iron need together; for women who cannot tolerate the iron component, a folic-acid-only tablet can be obtained separately.

Folic acid has a strong safety record at recommended doses. The standard 400 mcg pre-conception and 600 mcg pregnancy doses are well within the established upper safe intake limit of 1000 mcg (1 mg) per day from supplements for the general adult population. There is no toxicity risk at these doses, no risk of overdose from a normal supplement, and no need for blood monitoring of folate levels for healthy women on routine doses.

The high-dose 4 to 5 mg regimen prescribed for high-risk women is also considered safe in pregnancy, but at this dose there is a recognised concern about masking an underlying vitamin B12 deficiency. Folic acid corrects the anaemia of B12 deficiency without correcting the underlying B12 problem, which can allow the neurological damage of untreated B12 deficiency to progress silently. This is particularly relevant in India where vegetarian diets and pernicious anaemia make B12 deficiency common. The practical rule is that any woman on high-dose folic acid should have a vitamin B12 level checked first and supplemented if low — this is part of routine high-risk OB care.

Side effects of folic acid at any dose are uncommon and generally mild — occasional nausea, bloating or a metallic taste, which usually settle within a few days or with a brand switch.

A pre-conception OB visit is one of the most useful but underused medical visits in Indian reproductive care. The ideal time is 3 to 6 months before trying to conceive, and the visit covers a full review of medical and obstetric history, current medications (some are unsafe in pregnancy and need adjustment), vaccination status (rubella varicella hepatitis B influenza), and a baseline blood panel. Standard tests include haemoglobin and complete blood count, ferritin (iron stores), vitamin B12, vitamin D, TSH (thyroid), fasting glucose and HbA1c (diabetes), and for selected women MTHFR genotyping or homocysteine.

The OB will prescribe the right folic acid dose for the individual — 400 mcg for low-risk women, 4 to 5 mg for high-risk women — and will treat any anaemia or vitamin deficiency before pregnancy rather than after. The visit also covers lifestyle topics including weight diet exercise alcohol smoking and stress, and answers questions about cycle tracking and timing of intercourse for conception. For women with a chronic condition like diabetes hypothyroidism epilepsy or hypertension, the pre-conception visit is the moment to optimise control before pregnancy, which substantially improves outcomes. Government PMSMA clinics offer free OB consultation on the 9th of every month and eSanjeevani telehealth is available across India.